Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
14.65
+0.54 (3.83%)
At close: Jul 9, 2026, 4:00 PM EDT
14.63
-0.02 (-0.14%)
Pre-market: Jul 10, 2026, 6:46 AM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $1.53 billion as of July 10, 2026. Its market cap has increased by 181.97% in one year.
Market Cap
1.53B
Enterprise Value
1.34B
1-Year Change
181.97%
Ranking
Category
Stock Price
$14.65
Market Cap Chart
Since June 20, 2019, Personalis's market cap has increased from $847.61M to $1.53B, an increase of 81.00%. That is a compound annual growth rate of 8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.53B | 117.03% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sotera Health Company | 5.14B |
| Veracyte | 4.71B |
| Adaptive Biotechnologies | 3.50B |
| GRAIL | 3.22B |
| GeneDx Holdings | 2.09B |
| NeoGenomics | 1.92B |
| CareDx | 1.49B |
| OPKO Health | 1.05B |